IP Library Granted Patent US 8,334,272
Granted Patent B2
US 8,334,272 · App. 12/902,240 · Granted Dec 18, 2012

Methods for nucleic acid transfer into cells

Assignee: Northwestern University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,334,272
App. No.
12/902,240
Granted
Dec 18, 2012
Kind
B2
Abstract

The present invention provides methods for increasing the transfer of nucleic acids into cells. In particular, the present invention provides for the use of inhibitors of HDAC6, a cytoplasmic histone deacetylase present in mammalian cells by, for example, small molecules or siRNA treatment, in increasing gene transfer and/or expression in cells in vitro and in vivo for research and gene therapy applications.

Claims (13)

1. A method for increasing nucleic acid expression in cells comprising:

a) providing:

i) a gene transfer system, wherein said gene transfer system comprises lipids,

ii) a specific inhibitor of major tubulin deacetylase 6 (HDAC6), wherein said specific inhibitor inhibits HDAC6 without inhibiting other HDACs,

iii) mammalian cells, and

iv) a vector, and

b) contacting said cells with said vector and said specific inhibitor of HDAC6 in the presence of said gene transfer system such that gene expression from said vector is increased at least 2.5 fold in the presence of said specific inhibitor of HDAC6 compared to expression when said specific inhibitor of HDAC6 is absent, wherein said cells are contacted with said specific inhibitor of HDAC6 together with, or immediately after said contacting with, said vector.

2. The method of claim 1 , wherein the gene transfer system comprises an electroporation system.

3. The method of claim 1 , wherein the gene transfer system is calcium chloride.

4. The method of claim 1 , wherein the gene transfer system is DEAE/dextran.

5. The method of claim 1 , wherein said specific inhibitor of HDAC6 is compound 17b.

6. The method of claim 1 , wherein said cells are in vitro.

7. The method of claim 1 , wherein said cells are in vivo.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 6, 2013
From: NORTHWESTERN UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030572/0364 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2010
From: DEAN, DAVID A.; GEIGER, ROBERT CHRISTOPHER
To: NORTHWESTERN UNIVERSITY
Reel/Frame 025122/0543 →
Continuity (3)
Continuation 12163152 · Jun 27, 2008
Provisional Application 60937445 · Jun 27, 2007
Related Publication 20110021608A1 · Jan 27, 2011